IBT welcomes new Business Analyst
September 2, 2016
IBT welcomes Crescent Yingyue Liao as Business Analyst.
Crescent holds a Bachelor’s degree in Biochemistry and a Master’s degree in Bioentrepreneurship.
Read more IBT team here
Latest press releases
2026-03-03 07:00
Infant Bacterial Therapeutics (IBT) publishes results from ”The Connection Study” in Pediatric Research
2026-02-06 07:30
Infant Bacterial Therapeutics AB (publ) Year-end-report January 1 – December 31, 2025
Regulatory
2025-12-11 18:05
Infant Bacterial Therapeutics secures partnership with BioConnection for production of Drug Product
2025-11-25 18:41
IBT changes the IBP-9414 pathway for approval following discussions with the FDA
Regulatory
MAR
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2026